Thalassaemia usually requires lifelong treatment with blood transfusions and medication.
Children and adults with thalassaemia will be supported by a team of different healthcare professionals working together at a specialist thalassaemia centre.
Your healthcare team will help you learn more about thalassaemia and work with you to come up with an individual care plan that takes all your needs and health concerns into account.
Most people with thalassaemia major or other severe types will need to have regular blood transfusions to treat anaemia.
This involves being given blood through a tube inserted into a vein in your arm. It's usually done in hospital and takes a few hours each time.
How often you need to have transfusions depends on the type of thalassaemia you have.
People with the most severe type, beta thalassaemia major, may need a blood transfusion about once a month. Those with less severe types may only need them occasionally.
Blood transfusions are very safe, but they can cause too much iron to build up in the body, so you'll need to take medicine to remove the excess iron.
Treatment to remove excess iron caused by regular blood transfusions is known as chelation therapy.
It's very important because high levels of iron in the body can damage organs.
The treatment will usually need to start once you or your child has had around 10 blood transfusions.
Medicines used in chelation therapy are known as chelating agents.
There are 3 chelating agents currently available:
Each medicine has its own advantages and disadvantages. Your healthcare team will help you decide which is likely to be best for you or your child.
Stem cell or bone marrow transplants are the only cure for thalassaemia, but they're not done very often because of the significant risks involved.
Stem cells are produced in bone marrow, the spongy tissue found in the centre of some bones, and have the ability to develop into different types of blood cells.
For a stem cell transplant, stem cells from a healthy donor are given through a drip into a vein.
These cells then start to produce healthy red blood cells to replace the cells affected by thalassaemia.
A stem cell transplant is an intensive treatment that carries a number of risks.
The main risk is graft versus host disease, which is a life-threatening problem where the transplanted cells start to attack the other cells in your body.
For people with serious types of thalassaemia, the long-term benefits of a stem cell transplant will need to be considered against the possible risks to help determine whether the treatment is suitable.
Thalassaemia can also cause a number of other health problems that may need to be treated.